Cleared Traditional

K925197 - PSI 220 DUAL EMG

K925197 is an FDA 510(k) clearance for PSI 220 DUAL EMG, manufactured by Fasstech. The device is a Class 2 Neurology device with product code HCC cleared through the Traditional 510(k) pathway after a 110-day FDA review.

K925197 · Fasstech · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1993
Decision
110d
Days
Class 2
Risk

K925197 is an FDA 510(k) clearance for the PSI 220 DUAL EMG. Classified as Device, Biofeedback (product code HCC), Class II - Special Controls.

Submitted by Fasstech (Burlington, US). The FDA issued a Cleared decision on February 2, 1993 after a review of 110 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5050 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Fasstech devices

FDA 510(k) Submission Details - K925197

510(k) Number K925197 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 1992
Decision Date February 02, 1993
Days to Decision 110 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
38d faster than avg
Panel avg: 148d · This submission: 110d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HCC Device Classification - Class 2, Special Controls

Product Code HCC Device, Biofeedback
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HCC Device, Biofeedback

All 43
Devices cleared under the same product code (HCC) and FDA review panel - the closest regulatory comparables to K925197.
DIGITAL CONDUCTANCE METER
K924313 · The Jayms Co. · Mar 1996
ORALSENSOR
K953257 · Cycura Corp. · Feb 1996
J & J I-330 SERIES PHYSIOLOGICAL MONITORING & BIOFEEDBACK INSTUMENT AND USE SOFTWARE APPLICATIONS
K945826 · Medical Device Inspection Co., Inc. · Aug 1995
MYOTRAC2
K915858 · Thought Technology , Ltd. · Sep 1992
MYOTRAC/S, MYODAC/S
K915859 · Thought Technology , Ltd. · Sep 1992
MYOTRAC+/S, MYODAC+/S
K913898 · Thought Technology , Ltd. · Mar 1992